nat rev drug discov.2015 14475-86. pubmed 260912672. fung m thornton a mybeck k wu jh-h hornbuckle k muniz e. evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-1960 to 1999. drug inf j.

1998 2791200-5. pubmed 95557604. wishart ds.

drugs in r  d.2008 9307-22. pubmed 18721000wang et al.page 55. wilke ra lin dw roden dm watkins pb flockhart d zineh i et al.

2007 6904-16. pubmed 179717856. raamsdonk lm teusink b broadhurst d zhang n hayes a walsh mc et al.

2002 1153-61. pubmed 121200978. watkins pb.

2009 29393-9. pubmed 198269739. gallagher wm tweats d koenig j. omic profiling for drug safety assessment current trends and public-private partnerships.

2009 14337-42. pubmed 1934092810. urban tj goldstein db watkins pb.

2012 13735-8. pubmed 2259450211. gao y holland rd yu lr.

2009 8158-66. pubmed 1935168212. cui y paules rs.

2010 11573-85. pubmed 2035013913. fiehn o. metabolomics--the link between genotypes and phenotypes.

2002 48155-71. pubmed 1186020714. kaddurah-daouk r kristal bs weinshilboum rm.

2008 48653-83. pubmed 1818410715. nicholson jk connelly j lindon jc holmes e. metabonomics a platform for studying drug toxicity and gene function.

2002 1153-61. pubmed 1212009716. shintu l baudoin r navratil v prot jm pontoizeau c defernez m et al.

2012 841840-8. pubmed 2224272217. west pr weir am smith am donley el cezar gg.

2010 24718-27. pubmed 2049389818. kleinstreuer nc smith am west pr conard kr fontaine br weir-hauptman am et al.

